Compare LENZ & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | SEVN |
|---|---|---|
| Founded | 2019 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.5M | 184.4M |
| IPO Year | 2021 | 2008 |
| Metric | LENZ | SEVN |
|---|---|---|
| Price | $4.58 | $7.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $44.00 | $10.50 |
| AVG Volume (30 Days) | ★ 817.7K | 150.2K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | $19,088,000.00 | ★ $29,383,000.00 |
| Revenue This Year | $50.42 | $27.75 |
| Revenue Next Year | $197.16 | $4.06 |
| P/E Ratio | ★ N/A | $40.42 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.54 | $7.37 |
| 52 Week High | $50.19 | $11.15 |
| Indicator | LENZ | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 36.98 | 43.49 |
| Support Level | N/A | $7.41 |
| Resistance Level | $6.18 | $7.83 |
| Average True Range (ATR) | 0.41 | 0.14 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 2.49 | 60.53 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.